Mayo Clinic Proceedings

Mayo Clinic Proceedings is a general and internal medicine journal sponsored by Mayo Clinic and published by Elsevier. Founded on 21 April 1926 and appearing monthly, it has been online only since January 2021, carries print ISSN 0025-6196 and electronic ISSN 1942-5546, and reports a 2025 impact factor of 6.5.Mayo Clinic Proceedings 是梅奥诊所主办、爱思唯尔出版的综合性内科期刊，1926 年 4 月 21 日创刊，月刊，自 2021 年 1 月起仅在线出版，印刷版编号 0025-6196、电子版编号 1942-5546，2025 年影响因子为 6.5。^[1]

Scope

• Scope: one of the premier online only peer-reviewed clinical journals in general and internal medicine and among the most widely read and highly cited scientific publications for physicians, publishing articles that focus on clinical medicine and support the professional and educational needs of its readers.学科定位： 面向医师的在线同行评审临床期刊，是普通内科与综合医学领域阅读最广、被引最多的科学出版物之一，刊发聚焦临床医学并支持读者专业与教育需求的内容。^[1]
• Topics: clinical and experimental medicine, health policy and health economics, and medical education and ethics, with editorial responsibility additionally covering cardiovascular disease, oncology and haematology, nephrology, gastroenterology, neurology, infectious disease, endocrinology, pain medicine and biostatistics.收录主题： 临床医学与实验医学，卫生政策与卫生经济学，医学教育与医学伦理，编委分工另覆盖心血管、肿瘤与血液、肾脏、消化、神经、感染病、内分泌、疼痛医学与生物统计等。
• Article types: original articles, reviews, concise reviews for clinicians, understanding disease features, my treatment approach pieces, consensus recommendations, clinical practice guidelines, special articles, commentaries, perspectives and controversies, editorials, correspondence, medical images, case reports and residents' clinics.文章体裁： 原创论文、综述、临床医生简明综述、疾病解析、我的治疗路径、共识推荐、临床实践指南、专题文章、评论、观点与争议、社论、通信、医学图像、病例报告与住医临床教学等。^[2]
• Publishing model: hybrid, with authors choosing between an open access route carrying an article processing charge and a subscription route free of publication charges.出版模式： 混合开放获取，作者可选开放获取并支付版面费，或经订阅路径免费发表。
• Indexing and metrics: covered by the SCIE, Scopus and PubMed and archived in PubMed Central, with a 2025 impact factor of 6.5, a five-year impact factor of 7.5 and a CiteScore of 10.9.收录与指标： 被 SCIE、Scopus、PubMed 收录并在 PubMed Central 存档，2025 年影响因子 6.5、五年影响因子 7.5、CiteScore 10.9。

History

• Founded: the first issue appeared on 21 April 1926, growing out of the weekly staff meetings of the Mayo brothers, with case discussions transcribed and developed into a formal journal by Maude Mellish Wilson, Mayo's first institutional librarian, and the journal marks its centenary in 2026.创刊： 1926 年 4 月 21 日创刊，源自梅奥兄弟每周（staff meetings）的病例讨论，由梅奥首位机构图书馆员 Maude Mellish Wilson 整理会议记录发展为正式期刊，2026 年迎来创刊百年。^[3]
• Title history: launched as the Bulletin of the Mayo Clinic and Mayo Foundation, the journal was retitled Proceedings of the Staff Meetings of the Mayo Clinic from 1927 and renamed Mayo Clinic Proceedings in 1964 to reflect its professional stature under an editor-in-chief and editorial board.更名史： 创刊时名 Bulletin of the Mayo Clinic and Mayo Foundation，1927 年起改称 Proceedings of the Staff Meetings of the Mayo Clinic，1964 年更名为 Mayo Clinic Proceedings 以反映其在主编与编委会主持下的专业地位。^[4]
• Digital transition: from January 2021 the journal ceased print publication and moved online only.数字化转型： 2021 年 1 月起停止印刷版，改为仅在线出版。^[5]
• Scholarly tradition: the journal has published Nobel-prize-winning research and reached volume 101 by 2026.学术传统： 刊物曾发表诺贝尔奖级别的医学研究成果，2026 年为第 101 卷。

Editors

• Editor-in-chief: Karl A. Nath, MBChB, of the Division of Nephrology and Hypertension at Mayo Clinic in the United States, working on the physiology and pathology of renal disease and hypertension, editor-in-chief since 2017.现任主编： Karl A. Nath，医学学士与外科学士，梅奥诊所肾脏病与高血压科，研究方向为肾脏病与高血压的生理与病理，2017 年起任主编。^[6]
• Editorial board: the official editorial board page counts 77 editors and editorial board members from 8 countries and regions, 69 of them in the United States, comprising 12 associate editors, some 25 section editors, some 28 editorial board members and 8 statistical reviewers.编委构成： 官方编委页统计共 77 位编辑与编委，来自 8 个国家与地区，其中美国 69 人；含副编辑 12 名、栏目编辑约 25 名、编辑委员会约 28 名与统计审稿人 8 名。
• Managing editor: Terry Jopke serves as managing editor.执行编辑： Terry Jopke 任管理编辑。
• Submission and review: submissions go through Editorial Manager under single anonymized review, with at least two independent reviewers per manuscript, statistical methodological review for original articles, and adherence to COPE guidelines.投稿与评审： 经 Editorial Manager 系统投稿，实行单盲评审，每篇至少送 2 名独立审稿人，原创论文另经统计学家方法学审查，并遵循国际出版伦理委员会指南。
• Rapid review pathway: a rapid review pathway accepts manuscripts rejected elsewhere, provided the reviewer comments can be answered.快速通道： 设快速评审通道，被他刊高影响因子期刊退稿但评审意见可回应者可申请转入。